Eprosartan modulates the reflex activation of the sympathetic nervous system in sodium restricted healthy humans

British Journal of Clinical Pharmacology

Volumn 65, Issue 6, 2008, Pages 822-832

  Vase, Henrik ^a,b   Lauridsen, Thomas G ^b   Bech, Jesper N ^b   Pedersen, Erling B ^b  

^a HOLSTEBRO HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Angiotensin II type 1 receptor blockers; Blood pressure; Glomerular filtration rate; Natriuresis; Reflex; Sodium restricted

Indexed keywords

EPROSARTAN; LITHIUM; NITROPRUSSIDE SODIUM; NORADRENALIN; PLACEBO;

ADRENERGIC SYSTEM; ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; COLD PRESSOR TEST; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIURESIS; DOUBLE BLIND PROCEDURE; FEMALE; GLOMERULUS FILTRATION RATE; HEART RATE; HEMODYNAMICS; HUMAN; KIDNEY TUBULE FUNCTION; MALE; MEAN ARTERIAL PRESSURE; NORADRENALIN BLOOD LEVEL; NORMAL HUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; SODIUM RESTRICTION; SODIUM URINE LEVEL;

ACRYLATES; ADULT; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BLOOD PRESSURE; DIET, SODIUM-RESTRICTED; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; IMIDAZOLES; MALE; NATRIURESIS; SODIUM, DIETARY; SYMPATHETIC NERVOUS SYSTEM; THIOPHENES;

EID: 43849084219     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2008.03149.x     Document Type: Article

References (47)

1. Reid IA. Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am J Physiol 1992 262: E763 E778.
2. Saxena PR. Interaction between the renin-angiotensin-aldosterone and sympathetic nervous systems. J Cardiovasc Pharmacol 1992 19 Suppl 6: S80 S88.
3. Balt JC, Mathy MJ, Pfaffendorf M, van Zwieten PA. Inhibition of facilitation of sympathetic neurotransmission and angiotensin II-induced pressor effects in the pithed rat: comparison between valsartan, candesartan, eprosartan and embusartan. J Hypertens 2001 19: 2241 50.
4. Balt JC, Mathy MJ, Nap A, Pfaffendorf M, van Zwieten PA. Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery. J Cardiovasc Pharmacol 2001 38: 141 8.
5. Balt JC, Mathy MJ, Nap A, Pfaffendorf M, van Zwieten PA. Prejunctional and postjunctional inhibitory actions of eprosartan and candesartan in the isolated rabbit mesenteric artery. J Cardiovasc Pharmacol 2002 40: 50 57.
6. Dendorfer A, Raasch W, Tempel K, Dominiak P. Comparison of the vascular and antiadrenergic activities of four angiotensin II type 1 antagonists in the pithed rat. J Hypertens 2002 20: 1151 6.
7. Ohlstein EH, Brooks DP, Feuerstein GZ, Ruffolo RR, Jr. Inhibition of sympathetic outflow by the angiotensin II receptor antagonist, eprosartan, but not by losartan, valsartan or irbesartan: relationship to differences in prejunctional angiotensin II receptor blockade. Pharmacology 1997 55: 244 51.
8. Shetty SS, DelGrande D. Differential inhibition of the prejunctional actions of angiotensin II in rat atria by valsartan, irbesartan, eprosartan, and losartan. J Pharmacol Exp Ther 2000 294: 179 86.
9. Israel A, Zavala LE, Cierco M, Gutierrez A, del Rosario GM. Effect of eprosartan on the sympathetic response to cold pressor test in healthy volunteers. Auton Neurosci 2006 126 127: 179 84.
10. Christensen M, Ibsen H, Worck R. Effect of eprosartan on catecholamines and peripheral haemodynamics in subjects with insulin-induced hypoglycaemia. Clin Sci (Lond) 2005 108: 113 19.
11. Frank H, Schobel HP, Vitkowsky J, Schmieder RE, Heusser K. Effects of angiotensin II receptor antagonism on the renal hemodynamic response to cardiovascular stress. Kidney Int 2003 63: 617 23.
12. Krum H, Lambert E, Windebank E, Campbell DJ, Esler M. Effect of angiotensin II receptor blockade on autonomic nervous system function in patients with essential hypertension. Am J Physiol Heart Circ Physiol 2006 290: H1706 H1712.
13. Struck J, Muck P, Trubger D, Handrock R, Weidinger G, Dendorfer A, Dodt C. Effects of selective angiotensin II receptor blockade on sympathetic nerve activity in primary hypertensive subjects. J Hypertens 2002 20: 1143 9.
14. Worck RH, Ibsen H, Frandsen E, Dige-Petersen H. AT1 receptor blockade and the sympathoadrenal response to insulin-induced hypoglycemia in humans. Am J Physiol 1997 272: E415 E421.
15. Wuerzner G, Chiolero A, Maillard M, Nussberger J, Brunner HR, Burnier M. Angiotensin II receptor blockade prevents acute renal sodium retention induced by low levels of orthostatic stress. Kidney Int 2004 65: 238 44.
16. Heusser K, Vitkovsky J, Raasch W, Schmieder RE, Schobel HP. Elevation of sympathetic activity by eprosartan in young male subjects. Am J Hypertens 2003 16: 658 64.
17. De TE, Iacoviello M, Romito R, Ceconi C, Guida P, Massari F, Francolini G, Bertocchi F, Ferrari R, Rizzon P, Pitzalis MV. Comparison of the effect of valsartan and lisinopril on autonomic nervous system activity in chronic heart failure. Am Heart J 2003 146: E17.
18. Grassi G, Seravalle G, Dell'Oro R, Trevano FQ, Bombelli M, Scopelliti F, Facchini A, Mancia G. Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: results of the CROSS study. J Hypertens 2003 21: 1761 9.
19. Neumann J, Ligtenberg G, Klein IHT, Boer P, Oey PL, Koomans HA, Blankestijn PJ. Sympathetic Hyperactivity in Hypertensive Chronic Kidney Disease Patients Is Reduced During Standard Treatment. Hypertension 2007 49: 506 10.
20. Kramer HJ, Stinnesbeck B, Klautke G, Kipnowski J, Klingmueller D, Glaenzer K, Duesing R. Interaction of renal prostaglandins with the renin-angiotensin and renal adrenergic nervous systems in healthy subjects during dietary changes in sodium intake. Clin Sci (Lond) 1985 68: 387 93.
21. Pedersen EB, Eiskjaer H, Madsen B, Danielsen H, Egeblad M, Nielsen CB. Effect of captopril on renal extraction of renin, angiotensin II, atrial natriuretic peptide and vasopressin, and renal vein renin ratio in patients with arterial hypertension and unilateral renal artery disease. Nephrol Dial Transplant 1993 8: 1064 70.
22. Jensen KT, Carstens J, Ivarsen P, Pedersen EB. A new, fast and reliable radioimmunoassay of brain natriuretic peptide in human plasma. Reference values in healthy subjects and in patients with different diseases. Scand J Clin Lab Invest 1997 57: 529 40.
23. Pedersen RS, Bentzen H, Bech JN, Pedersen EB. Effect of water deprivation and hypertonic saline infusion on urinary AQP2 excretion in healthy humans. Am J Physiol Renal Physiol 2001 280: F860 F867.
24. Victor RG, Leimbach WN, Jr., Seals DR, Wallin BG, Mark AL. Effects of the cold pressor test on muscle sympathetic nerve activity in humans. Hypertension 1987 9: 429 36.
25. Yamamoto K, Iwase S, Mano T. Responses of muscle sympathetic nerve activity and cardiac output to the cold pressor test. Jpn J Physiol 1992 42: 239 52.
26. Fyhrquist F, Saijonmaa O, Metsarinne K, Tikkanen I, Rosenlof K, Tikkanen T. Raised plasma endothelin-I concentration following cold pressor test. Biochem Biophys Res Commun 1990 169: 217 21.
27. Mitchell A, Rushentsova U, Siffert W, Philipp T, Wenzel RR. The angiotensin II receptor antagonist valsartan inhibits endothelin 1-induced vasoconstriction in the skin microcirculation in humans in vivo: influence of the G-protein beta3 subunit (GNB3) C825T polymorphism. Clin Pharmacol Ther 2006 79: 274 81.
28. DiBona GF, Kopp UC. Neural control of renal function. Physiol Rev 1997 77: 75 197.
29. Ebert TJ, Cowley AW, Jr. Baroreflex modulation of sympathetic outflow during physiological increases of vasopressin in humans. Am J Physiol 1992 262: H1372 H1378.
30. Grassi G, Turri C, Dell'Oro R, Stella ML, Bolla GB, Mancia G. Effect of chronic angiotensin converting enzyme inhibition on sympathetic nerve traffic and baroreflex control of the circulation in essential hypertension. J Hypertens 1998 16: 1789 96.
31. Noll G, Wenzel RR, de MS, Shaw S, Luscher TF. Differential effects of captopril and nitrates on muscle sympathetic nerve activity in volunteers. Circulation 1997 95: 2286 92.
32. Miyajima E, Shigemasa T, Yamada Y, Tochikubo O, Ishii M. Angiotensin II blunts, while an angiotensin-converting enzyme inhibitor augments, reflex sympathetic inhibition in humans. Clin Exp Pharmacol Physiol 1999 26: 797 802.
33. DiBona GF, Jones SY, Sawin LL. Effect of endogenous angiotensin II on renal nerve activity and its cardiac baroreflex regulation. J Am Soc Nephrol 1998 9: 1983 9.
34. Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Bolla G, Mancia G. Baroreflex impairment by low sodium diet in mild or moderate essential hypertension. Hypertension 1997 29: 802 7.
35. Grassi G, Dell'Oro R, Seravalle G, Foglia G, Trevano FQ, Mancia G. Short- and long-term neuroadrenergic effects of moderate dietary sodium restriction in essential hypertension. Circulation 2002 106: 1957 61.
36. Kamiya A, Kawada T, Yamamoto K, Michikami D, Ariumi H, Miyamoto T, Shimizu S, Uemura K, Aiba T, Sunagawa K, Sugimachi M. Dynamic and static baroreflex control of muscle sympathetic nerve activity (SNA) parallels that of renal and cardiac SNA during physiological change in pressure. Am J Physiol Heart Circ Physiol 2005 289: H2641 H2648.
37. Kotridis P, Kokkas B, Karamouzis M, Sakadamis G, Kanonidis I, Dadous G, Karantona C, Gouli O, Karadoumanis J, Papadopoulos PC, Papadopoulos CL. Plasma atrial natriuretic peptide in essential hypertension after treatment with irbesartan. Blood Press 2002 11: 91 4.
38. Sata N, Tanaka Y, Suzuki S, Kamimura R, Mifune H, Nakamura K, Miyahara K, Arima T. Effectiveness of angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker on atrial natriuretic peptide. Circ J 2003 67: 1053 8.
39. Ebert TJ, Cowley AW, Jr. Atrial natriuretic factor attenuates carotid baroreflex-mediated cardioacceleration in humans. Am J Physiol 1988 254: R590 R594.
40. Volpe M. Atrial natriuretic peptide and the baroreflex control of circulation. Am J Hypertens 1992 5: 488 93.
41. Floras JS. Inhibitory effect of atrial natriuretic factor on sympathetic ganglionic neurotransmission in humans. Am J Physiol 1995 269: R406 R412.
42. Thomas CJ, Woods RL. Do natriuretic peptides modify arterial baroreflexes in sheep? Exp Physiol 2004 89: 709 15.
43. Thomsen K. Lithium clearance: a new method for determining proximal and distal tubular reabsorption of sodium and water. Nephron 1984 37: 217 23.
44. Boer WH, Koomans HA, Dorhout Mees EJ, Gaillard CA, Rabelink AJ. Lithium clearance during variations in sodium intake in man: effects of sodium restriction and amiloride. Eur J Clin Invest 1988 18: 279 83.
45. Koomans HA, Boer WH, Dorhout Mees EJ. Evaluation of lithium clearance as a marker of proximal tubule sodium handling. Kidney Int 1989 36: 2 12.
46. Martin EA, Charkoudian N. Changes in central venous pressure with vasoactive drug injections in humans. Clin Auton Res 2005 15: 121 5.
47. Charkoudian N, Martin EA, Dinenno FA, Eisenach JH, Dietz NM, Joyner MJ. Influence of increased central venous pressure on baroreflex control of sympathetic activity in humans. Am J Physiol Heart Circ Physiol 2004 287: H1658 H1662.